Skip to main content
. 2023 May 31;13:8869. doi: 10.1038/s41598-023-35527-4

Table 3.

Genetic determinants of antibiotic resistance in H. pylori CHC155 and VN1291.

Antibiotic Minimum inhibitory concentration (mg/L) Phenotype Gene Mutation site
(a) Strain CHC155
 Amoxicillin 0.06 S pbp1 (HP0597) N.D
 Clarithromycin 4 R 2 copies of 23S rRNA A2147G
 Levofloxacin 8 R gyrA (HP0701) N87K
 Metronidazole 32 R rdxA (HP0954) T31E, H53R, D59N, Q65*
frxA N.D
 Tetracycline 0.12 S 2 copies of 16S rRNA N.D
(b) Strain VN1291
 Amoxicillin 0.5 R pbp1 (HP0597) F366L, S414R, K464insE, D473E
 Clarithromycin 4 R 2 copies of 23S rRNA A2147G
 Levofloxacin 0.5 S gyrA (HP0701) N.D
 Metronidazole > 256 R rdxA (HP0954) Frameshifted, insertion/deletion at approximately position 1,114,371
frxA N.D
 Tetracycline 0.125 S 2 copies of 16S rRNA N.D

S Susceptible, R resistant. Determined by cut off value according to the European Committee on Antimicrobial Susceptibility Testing (EUCAST) clinical breakpoint (2021-01-01). S is equal to or less than the cut-off value and R is more than the cut-off value. The cut offs (mg/L) were; amoxicillin (0.125), levofloxacin (1), clarithromycin (0.25), tetracycline (1), and metronidazole (8). N.D. not detected.